Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FREVS | Common Stock, par value $0.01 per share | Other | +14.6K | +7.55% | 209K | Jan 27, 2023 | Direct | F1, F2 | ||
holding | FREVS | Common Stock, par value $0.01 per share | 102K | Jan 27, 2023 | By Partnerships and LLCs | F1, F3 | |||||
holding | FREVS | Common Stock, par value $0.01 per share | 17.6K | Jan 27, 2023 | By Trust | F1, F4 | |||||
holding | FREVS | Common Stock, par value $0.01 per share | 25.5K | Jan 27, 2023 | By Trust | F1, F5 | |||||
holding | FREVS | Common Stock, par value $0.01 per share | 88.9K | Jan 27, 2023 | By Foundation | F1, F6 | |||||
holding | FREVS | Common Stock, par value $0.01 per share | 6K | Jan 27, 2023 | By Trust | F1, F7 | |||||
holding | FREVS | Common Stock, par value $0.01 per share | 1.92K | Jan 27, 2023 | By Spouse | F1, F8 |
Id | Content |
---|---|
F1 | Prior to the reincorporation of First Real Estate Investment Trust of New Jersey, Inc. ("FREIT") from a New Jersey real estate investment trust to a Maryland corporation on July 1, 2021, FREIT's equity securities were beneficial interests in FREIT that were designated as "shares" without par value. In connection with the reincorporation of FREIT as a Maryland corporation, FREIT's shares of beneficial interest were converted to shares of common stock, par value $0.01 per share, on a 1-for-1 basis. |
F2 | As disclosed in FREIT's filings with the Securities and Exchange Commission, on November 4, 2021, FREIT's Board of Directors approved the termination of FREIT's Amended and Restated Deferred Fee Plan. In connection with the termination of the Amended and Restated Deferred Fee Plan, all Share Units credited to each participant's account for the deferral of fees under the Amended and Restated Deferred Fee Plan were distributed to the participants as shares of FREIT's common stock, par value $0.01 per share. The filing of FREIT's Annual Report on Form 10-K for the fiscal year ended October 31, 2022 on January 27, 2023 served as notice of the execution of the distribution of such shares under the Amended and Restated Deferred Fee Plan to the reporting person. |
F3 | Shares held by certain partnerships and limited liability companies in which Mr. Hekemian is a partner or member. Mr. Hekemian disclaims beneficial ownership of the shares held by such partnerships and limited liability companies except to the extent of his pecuniary interest therein. |
F4 | Shares held in by a certain trust for the benefit of Mr. Hekemian's nephews, of which Mr. Hekemian is the trustee. Mr. Hekemian disclaims beneficial ownership of the shares held by such trust. |
F5 | Shares held in a certain trust, of which Mr. Hekemian is a beneficiary. Mr. Hekemian disclaims beneficial ownership of the shares held by such trust except to the extent of his pecuniary interest therein. |
F6 | Shares held by the Robert and Mary Jane Hekemian Foundation, Inc., of which Mr. Hekemian is the Vice President/Treasurer. Mr. Hekemian disclaims beneficial ownership of the shares held by the Robert and Mary Jane Hekemian Foundation, Inc. |
F7 | Shares held in a certain trust for the benefit of Mr. Hekemian's children, of which Mr. Hekemian is the trustee. Mr. Hekemian disclaims beneficial ownership of the shares held by such trust. |
F8 | Shares held by Mr. Hekemian's wife. Mr. Hekemian disclaims beneficial ownership of the shares held by his wife. |